- Price is above Fair Value, showing premium demand versus the model.
NTR
NYSE
Week ended 24 Jul 2026
Weekly Investor Report
Nutrien Ltd · Basic Materials · Agricultural Inputs
Latest close
68.10 USD
1.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -1.9% below the Trend Line and sits at 48.9% of its 52-week range. The latest completed week returned 1.2%, after a 12.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. Options positioning is bullish with 37/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 6d.
Setup score
46
out of 100
Latest Close
68.10 USD
24 Jul 2026
1W Return
1.2%
latest completed week
4W Return
12.7%
short-term follow-through
12W Return
-8.7%
quarterly tape
Trend Breadth
73.1%
38 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.2%
Latest completed week; four-week move 12.7%.
Indicator stack
40/37
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Options pressure
Bullish
37/100 conviction; expected move 3.7%.
News sentiment
51/100
65 relevant articles in the latest sentiment read.
Event risk
6d
Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -1.9% below the Trend Line and sits at 48.9% of its 52-week range. The latest completed week returned 1.2%, after a 12.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1612-week average 0.49
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.7% over four weeks, -8.7% over 12 weeks, and 16.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year38
Trend breadth73.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.84Latest activity-pressure read.
Pressure change23.9%Four-week change in activity pressure.
Leadership-1.83Latest relative-leadership reading.
RS change84.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 100%
Model confidence 96%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength86/100Blend of value, momentum, and quality. Underlying universe rank 15; rank 1 is best.
Value89/100Relative valuation strength. Underlying universe rank 12; rank 1 is best.
Quality73/100Profitability and accounting quality. Underlying universe rank 28; rank 1 is best.
Momentum35/100Medium-term price momentum. Underlying universe rank 66; rank 1 is best.
Growth98/100Revenue and earnings growth. Underlying universe rank 3; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework66/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 13.7x Price divided by trailing earnings.
- Price / sales
- 1.2x Market value relative to trailing revenue.
- EV / EBITDA
- 7.3x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 13.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 31.2% Gross profit retained from each unit of revenue.
- Operating margin
- 14.1% Operating profit retained from revenue.
- Free-cash-flow margin
- 22.8% Free cash flow generated from revenue.
- Return on invested capital
- 7.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 8.4% Latest one-year revenue growth.
- EPS growth
- 352.9% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 26.9% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 8/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.6% Cash dividends relative to market value.
- Buyback yield
- 1.4% Net share repurchases relative to market value.
- Shareholder yield
- 3.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
NTR shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.33, expected move of 3.7%, and Sharemaestro trend signal inactive.
Conviction37/100
Expected move3.7%
Put/call volume0.33
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 65 relevant articles.
18 positive · 35 neutral · 12 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings6dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move3.7%Nearest-chain priced movement where available.
52-week drawdown-19.6%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher15 of 2611 weeks finished lower.
Best week+8.7%Week of 13 Mar.
Worst week-9.8%Week of 20 Mar.
Latest week+1.2%Week of 24 Jul.
Shape of recent returns
Strong gains5
Modest gains10
Flat weeks0
Modest losses7
Sharp losses4
Recent vol4.5%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Basic Materials
4-week rank6 / 100
Group average-3.2%
Trend breadth28.0%
Trend28.0%active weekly trend signals
MD26.0%positive activity pressure
RS37.0%positive relative leadership
Four-week leaders
IndustryUS Agricultural Inputs
4-week rank2 / 12
Group average4.3%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD25.0%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape43/100
Trend, activity pressure, participation, and risk combine to a 43/100 tape read.
Indicator analysis23/100Latest 12-week confirmation: trend 5/12, activity pressure 0/12, relative leadership 1/12.
Activity pressure 0.16; No reversal markers Factors71/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Cornerstone Growth rank 48; Buyback Yield rank 27 SVQF66/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 342.0 of 1013 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options44/100NTR shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.33, expected move of 3.7%, and Sharemaestro trend signal inactive.
Bullish · Call-side pressure · Expected move 3.7% Sentiment51/100Weighted news tone is neutral across 65 relevant articles.
Barclays Maintains Nutrien(NTR.US) With Buy Rating, Cuts Target Price to $81 Insiders50/100No recent insider transaction evidence is stored.
Earnings6dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 68.10 USD | 1.2% | 69.40 USD | 54.76 USD | -0.84 | -1.83 | 9.8M | Off |
| 17 Jul 2026 | 67.28 USD | 2.8% | 69.19 USD | 54.72 USD | -0.99 | -3.59 | 9.6M | Off |
| 10 Jul 2026 | 65.43 USD | 0.6% | 68.99 USD | 54.66 USD | -1.08 | -7.76 | 13.4M | Off |
| 3 Jul 2026 | 65.06 USD | 7.6% | 68.87 USD | 54.59 USD | -1.06 | -7.22 | 16.7M | Off |
| 26 Jun 2026 | 60.45 USD | -3.0% | 68.68 USD | 54.52 USD | -1.10 | -12.05 | 14.1M | Off |
| 19 Jun 2026 | 62.32 USD | -7.0% | 68.57 USD | 54.47 USD | -1.10 | -11.67 | 12.8M | Off |
| 12 Jun 2026 | 67.03 USD | 0.6% | 68.34 USD | 54.41 USD | -1.05 | -4.42 | 17.2M | Off |
| 5 Jun 2026 | 66.62 USD | -2.0% | 68.05 USD | 54.32 USD | -1.01 | -4.71 | 14.5M | On |
| 29 May 2026 | 67.96 USD | -2.3% | 67.70 USD | 54.23 USD | -0.95 | -5.37 | 8.6M | On |
| 22 May 2026 | 69.52 USD | -2.0% | 67.22 USD | 54.11 USD | -0.80 | -1.94 | 11.0M | On |
| 15 May 2026 | 70.94 USD | 4.7% | 66.81 USD | 53.98 USD | -0.72 | 0.78 | 13.3M | On |
| 8 May 2026 | 67.74 USD | -9.2% | 66.33 USD | 53.88 USD | -0.61 | -3.55 | 20.3M | On |
| 1 May 2026 | 74.57 USD | 4.2% | 66.03 USD | 53.79 USD | -0.31 | 8.58 | 12.3M | On |
| 24 Apr 2026 | 71.57 USD | 1.3% | 65.49 USD | 53.68 USD | 0.08 | 5.31 | 11.1M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.